Up to 20% of the CLTI population is estimated to be unreconstructable by means of conventional revascularization techniques due to the absence of a viable target vessel or viable conduit, or the presence of other comorbidities. Without any possibility of revascularization, such “no-option” patients have a dire prognosis, and suffer a high burden of major amputation and mortality.
Percutaneous deep vein arterialization (pDVA) has recently been shown to provide a promising treatment alternative for no-option patients.
| File Name | Type | Permissions | Changed Date | Date | Size | ||||
|---|---|---|---|---|---|---|---|---|---|
pdf |
Promis I | 0644 | 2026021609174716-Feb-2026 09:17 | 2023032308340423-Mar-2023 08:34 | 1 MB | Preview | Download | ||
pdf |
et0515 F8 Kum | 0644 | 2026021609174716-Feb-2026 09:17 | 2022122604531926-Dec-2022 04:53 | 988 KB | Preview | Download | ||
pdf |
et0521 FT LimFlow | 0644 | 2026021609174716-Feb-2026 09:17 | 2022122604532026-Dec-2022 04:53 | 2 MB | Preview | Download | ||
pdf |
manzi2011 | 0644 | 2026021609174716-Feb-2026 09:17 | 2022122604531926-Dec-2022 04:53 | 3 MB | Preview | Download |
The information contained herein has been obtained from sources believed to be reliable. However, no warranty as to the accuracy, completeness or adequacy of such information is implied. No liability is accepted for errors, omissions or inadequacies in the information contained herein or for interpretations thereof. The reader assumes sole responsibility for the selection of these materials to achieve its intended results. The opinions expressed herein are subject to change without notice.
WEBDESIGN - PHOTOGRAPHY - GRAVENDEEL